VIRX Analysis

Viracta Therapeutics, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
2.46
Last session price
2.46
Price now
Currency: USD
Reporting currency: USD
ISIN: US8673287004
INN:
.

VIRX financial statements

* Numbers in thousands
Capitalization * 9 905
EV * 14 628
Number of shares * 4 027
EPS -5,37
Revenue * 120
Net income * -21 610
Operating profit * -22 303
Total liabilities * 3 310
Net debt * -20 137
Total assets * 23 247
Equity * 19 937
Cash and investments * 20 410
.

VIRX valuation

P/E -0,46
P/B 0,50
P/S 82,54
E/P -218
P/FCF -0,46
.

VIRX profitability

ROE -108%
ROA% -93%
ROIC% -112%